Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of CardiologyPetar Seferović, John J.V. McMurray, Mark C. Petrie et al.|European Journal of Heart Failure|2018Cited by 716
Inflammation – Cause or Consequence of Heart Failure or Both?Sophie Van Linthout, Carsten Tschöpe|Current Heart Failure Reports|2017Cited by 457
Right Heart Dysfunction and Failure in Heart Failure with Preserved Ejection Fraction: Mechanisms and Management. Position Statement on Behalf of the Heart Failure Association of the European Society of CardiologyThomas M. Gorter, Rudolf A. de Boer, Dirk J. van Veldhuisen et al.|European Journal of Heart Failure|2017Cited by 380
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of HypertensionStefan D. Anker, Giuseppe Rosano, Muhammad Usman et al.|European Journal of Heart Failure|2023Cited by 187
Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitusDirk Westermann, Carsten Tschöpe|Diabetologia|2006Cited by 157